Product Information
PILOCARPINE 4% EYE DROPS is a generic product labeled by Sandoz Inc., priced at $3.3759 per ML under NDC 61314020615. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 22, 2010. Its Orange Book therapeutic-equivalence code is AT.
Strength
40 mg/mL
Manufacturer
Sandoz Inc.NDC
61314020615
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
PILOCARPINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA200890FDA Approved
6/22/2010
TE Code
AT
On Market Since
9/30/2011
Pharmacological Classes
Price Statistics
The NADAC for PILOCARPINE 4% EYE DROPS has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 35.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.3759 per ML |
|---|---|
| All-time high | $5.6249 (Jun 15, 2016) |
| All-time low | $3.0272 (Jan 22, 2025) |
| 52-week high | $3.7569 |
| 52-week low | $3.2255 |
| Median price | $4.6058 |
| Average price | $4.4903 |
| Largest weekly change | -18.1% (Oct 17, 2018) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the pilocarpine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
pilocarpine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PILOCARPINE 4% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for PILOCARPINE 4% EYE DROPS, manufactured by Sandoz Inc., is $3.3759 per ML (NDC 61314020615), effective Sep 30, 2026.
How has the price of PILOCARPINE 4% EYE DROPS changed over time?
Over the history we have for it, the NADAC for PILOCARPINE 4% EYE DROPS has declined 35.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PILOCARPINE 4% EYE DROPS?
Since Nov 28, 2013, the NADAC for PILOCARPINE 4% EYE DROPS has ranged from a low of $3.0272 (Jan 22, 2025) to a high of $5.6249 (Jun 15, 2016), with a median of $4.6058 per ML.
Are there cheaper alternatives to PILOCARPINE 4% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of PILOCARPINE 4% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PILOCARPINE 4% EYE DROPS?
PILOCARPINE 4% EYE DROPS (NDC 61314020615) is labeled by Sandoz Inc., and CMS classifies it as a generic product.